Intellectual property

---

Arête has filed national patent applications for method of use and composition of matter in the United States, Canada, The European Union, China, Japan, Australia, and India.  Our therapy has succeeded in stopping the progression of multiple sclerosis (MS) and Alzheimer's Disease in proof of concept mouse models.  Future targets include Parkinson’s Disease, amyotrophic lateral sclerosis (ALS), Hashimoto's Disease, Graves Disease, Crohn's Disease, ulcerative colitis, and more.